Entering a strategic collaboration as a startup can be enormously beneficial to get your innovation to the next level, whether it is around product development, distribution, testing and validation.But the size of the partner and your preparation can make or break your growth strategy.
Join JLABS, Allen & Overy and O’Melveny to learn more and discuss key questions such as:
- Why collaborate?
- What are the key considerations when starting a collaboration?
- What are the basics of joint ventures?
- What are the IP considerations?
- How do you prepare for potential outcomes and exists?
- What is the impact of insolvency or bankruptcy of one of the parties on the licensing agreement?
We will also look at issues such as force majeure, and provide some 'real life examples' seen during the COVID-19 crisis.
Chioma advises on a broad range of technology and commercial matters, including IT outsourcing projects, complex commercial arrangements and specialised telecoms sector contracts. Chioma also has extensive experience advising clients on strategic and transformational IT projects, including advice on related intellectual property licensing and collaboration arrangements, and data protection issues. She also advises on technology project renegotiations and dispute management.
Tine focuses on IP law, EU life sciences regulatory law and privacy and EU data protection law. She advises and assists clients both in non-litigious and litigious matters in these areas.
Recent highlights of her practice include multi-jurisdictional advice on European plant and seed legislation and genetically modified organisms, clinical trials, complex cross-border data protection matters and medical devices.
Geoff focuses his practice on assisting clients, primarily in the life sciences sector, with intellectual property and technology-intense transactions. His work runs the gamut of complex transactions, from out-bound license and in-bound license, development, commercialization, strategic alliance and joint venture, collaboration, and profit sharing agreements to commercial agreements for distribution, manufacture, and supply, as well as intellectual property due diligence for strategic acquisitions and financings involving life sciences businesses, products, and patents.
Cosmin leads engagement activations for Johnson & Johnson Innovation, JLABS in Belgium and supports the broader EMEA region’s marketing, events and communications. Cosmin manages coordination of high-quality, diverse and distinctive programming ranging from one-on-one investor meetings, workshops to large panel series, networking, community and social events that serve JLABS and the broader EMEA entrepreneurial ecosystem.
Will is one of the global relationship partners for Johnson & Johnson. Will’s practice focuses on corporate and commercial matters with a particular emphasis on the tech sector and its related industries both in Europe and in the United States. From emerging enterprises and startups to large public corporations, Will advises some of the world’s leaders in technology on a range of issues including M&A, JVs, and corporate finance (including venture and growth capital transactions).
